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Background: South Korea has experienced problems regarding poor management of symptoms of asthma
patients and remarkable increases in sleep disorders. However, few studies have investigated these issues.
We examined the relationship between sleep disorders and mortality in asthma patients to suggest effective
alternatives from a novel perspective.
Methods: We used data from the National Health Insurance Service (NHIS) National Sample Cohort 2004–2013,
which included medical claims filed for 186,491 patients who were newly diagnosed with asthma during the
study period. We performed survival analyses using a Cox proportional hazards model with time-dependent
covariates to examine the relationship between sleep disorders and mortality in asthma patients.
Results: There were 5179 (2.78%) patients who died during the study period. Sleep disorders in patients
previously diagnosed with asthma were associated with a higher risk of mortality (hazard ratio [HR]: 1.451,
95% confidence interval [CI]: 1.253–1.681). In addition, significant interaction was found between sleep
disorders and Charlson comorbidity index.
Conclusions: Our findings suggest that an increased prevalence of sleep disorders in asthma patients increases
the risk of mortality. Considering the worsening status of asthma management and the rapid growth of sleep
disorders in South Korea, clinicians and health policymakers should work to develop interventions to address
these issues.
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Asthma is a common chronic disease largely caused by
genetic and environmental risk factors such as indoor
and outdoor allergens, smoking, chemical irritants in the
workplace, and air pollution. Its symptoms include recur-
ring periods of wheezing, chest tightness, shortness of
breath, and coughing [1]. In severe cases, asthma can lead
to death. According to a World Health Organization
(WHO) report, about 235 million people suffer from
asthma worldwide, and it is especially severe for children
in low- and middle-income countries [2]. Although asthma* Correspondence: ecpark@yuhs.ac
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and improve the quality of life of patients.
To determine the optimal management of asthma
patients, numerous previous studies have been conducted,
revealing many risk factors related to worsening status of
asthma patients including clinical, socioeconomic, seasonal,
and environmental factors [3–10]. Nevertheless, concerns
remain regarding the management of worsening asthma in
South Korea. According to the Organization for Economic
Co-operation and Development (OECD) Health at a
Glance 2015, asthma management in South Korea is worse
than in other OECD countries; specifically, hospital admis-
sion rates for asthma patients are 98.5 per 100,000 people
in South Korea compared to the average of 43.8 per
100,000 people in other OECD countries [11]. To solve the
problems related to inappropriate management, the Health
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essential to assess problems related the poor level of asthma
management from alternative perspectives. Here, we focus
on the link between outcomes of asthma patients and sleep
disorders. Sleep is intimately related to many aspects of an
individual’s life, and sleep disorders may contribute to both
physical and mental problems. According to previous
studies, sleep disorders and problems such as low quality of
sleep or short sleeping time could result in deteriorating
conditions in patients with chronic diseases, including
asthma, and in severe cases, sleep disorders were even
associated with mortality in patients [12–14].
In South Korea, sleep issues have become increasingly
common. According to National Health Insurance Service
(NHIS) reports, health resource utilization due to organic
sleep disorders (International Classification of Diseases
[ICD]-10: G47) has gradually increased in South Korea,
with the number of inpatients and outpatients growing
from 358,062 in 2012 to 380,876 in 2013 and 414,524 in
2014 [15]. Now, it has become a major concern that needs
to be solved and has even gained the media spotlight
recently. Despite these remarkable increases over the
last several years, few studies have investigated the
negative impact of sleep disorders in South Korea. In
this study, we analyzed the association between sleep
disorders and mortality as the outcome variable among
patients who were diagnosed with asthma, thereby consid-
ering the poor quality of asthma patient management and
considerable increases in sleep disorders in South Korea.
Based on this study, we expected to be able to develop
alternatives for the optimal management of asthma in
South Korea.
Methods
Study population
The data used in this study were obtained from the
NHIS National Sample Cohort 2002–2013 that was re-
leased in 2014. They comprised a nationally representative
random sample of 1,025,340 individuals, approximately
2.2% of the entire NHIS population in 2002. The data were
produced by the NHIS using a systematic sampling method
to generate a representative sample of 46,605,433 Korean
residents recorded in 2002. The database included all
medical claims filed from January 2002 to December
2013. To investigate the association between sleep dis-
orders and mortality in patients with diagnosed asthma,
we included only patients who were newly diagnosed
with asthma (ICD-10: J45) during outpatient care after
2004. We then excluded patients diagnosed with a sleep
disorder (ICD-10: G47) prior to the diagnosis of asthma
to limit our investigation to the effect of sleep disorders
on patients who had already experienced asthma. Ultim-
ately, the data used in this study were from 186,491 patients
newly diagnosed with asthma from 2004–2013. Regionalcharacteristics were determined from the “e-provincial
indicators” published by Statistics Korea, which con-
tained the regional demographic structures for all 253
basic administrative si-gun-gu (city-county-ward) districts
of South Korea. We classified the data based on the
si-gun-gu information to take into account the regional
characteristics of the community in which each patient re-
sided (Statistics Korea) [16].
Variables
The outcome variable was mortality in patients diag-
nosed with asthma (ICD-10: J45). Mortality was defined
as all types of death in patients with asthma during the
study period. We identified the date of each patient’s first
hospital visit through either outpatient care or admission
during the study period, and we followed each patient after
that date.
The primary independent variable in relation to the
mortality of patients with asthma was whether they were
diagnosed with an organic sleep disorder during follow-up
(ICD-10: G47). We adjusted both patient and regional
variables when analyzing the effect of sleep disorders
on mortality in patients with asthma. The patient variables
included in the analyses were sex, age, income, insurance
coverage type, year of first asthma diagnosis, disability,
Charlson comorbidity index score, and average annual
pharmaceutical expenditures for asthma. Age was divided
into 10-year groups (≤19, 20–29, 30–39, 40–49, 50–59, 60–
69, and ≥70 years) to reflect any differences in the effects of
sleep disorders on mortality among patients with asthma
by age group. Income level was categorized into deciles
based on mean household income as follows: ≤10%, 11%–
20%, 21%–30%, 31%–40%, 41%–50%, 51%–60%, 61%–70%,
71%–80%, 81%–90%, and ≥91%. The types of insurance
coverage were categorized as medical aid, National
Health Insurance (NHI) employee insurance, or NHI
self-employed insurance based on the NHI criteria. Those
with NHI employee insurance included workers and em-
ployers in all workplaces, public officials, private school
employees, continuously insured persons, and daily paid
workers at construction sites. Beneficiaries of NHI em-
ployee insurance included spouses, descendants, siblings,
and parents. People with NHI employee insurance paid a
regular portion (about 7%) of their average salary in contri-
bution payments, and the rates changed every year. The
NHI self-employed insurance category included people
who did not fall into the above-described group. Their
contribution amount was set by taking into account their
income, property, living standard, and rate of participation
in economic activities. Medical aid beneficiaries were
defined as patients with an income below the government-
defined poverty level or a disability who were provided
with free inpatient and outpatient care paid with govern-
ment funds. Therefore, the type of insurance coverage
Han et al. BMC Pulmonary Medicine  (2016) 16:154 Page 3 of 10represented each patient’s socioeconomic status [17, 18].
The first diagnosis for asthma was defined as the year that
each patient was initially diagnosed and was included
to reflect the duration of illness. Disability was classified as
none, mild, and severe to reflect the effect of disability on
worsening health outcomes in patients with asthma. The
Charlson comorbidity index was calculated by weighting
and scoring for comorbid conditions, with additional points
added to consider comorbidities that could affect health
outcomes of patients with asthma. Average annual pharma-
ceutical expenditures for asthma were calculated as the
average of the sum of pharmaceutical expenditures every
year after asthma diagnosis (ICD-10: J45). This could indir-
ectly reflect the level of treatment and asthma severity.
The regional variables were region, number of medical
centers per 1000 residents, population size, proportion
of seniors, and financial independence rate of the local
government. The region types were metropolitan and
other. Population size was defined as the total number
of residents in each community, and the proportion of
seniors was the number of elderly individuals among the
entire community. The financial independence rate of
the local government was an index of the finance utilization
capacity of a local government with independent discretion-
ary power. This indicator was calculated as follows: (local
taxes + non-tax revenue)/local government budgets × 100.
Statistical analysis
We first examined the frequencies and percentages of
each categorical variable at each patient’s baseline and
performed χ2 tests to examine the distribution for mor-
tality according to each variable. We examined the mean
and standard deviation of each continuous variable at
baseline and performed t-tests or Wilcoxon-Mann–Whitney
tests for each variable by mortality during the study period.
Analyses were performed for both patient- and regional-
level variables. Kaplan-Meier survival curves and log-rank
tests were used to compare survival rates between groups.
We performed survival analyses using a Cox proportional
hazards model with time-dependent covariates to examine
factors associated with mortality [19]. Subgroup ana-
lyses by age group, insurance coverage type, average an-
nual pharmaceutical expenditures for asthma, region,
CCI, and number of medical centers were used to investi-
gate the relationship between sleep disorders and mortality
in patients with asthma. All statistical analyses were
performed using SAS statistical software version 9.2
(Cary, NC).
Results
The data used in the analysis were collected from 186,491
patients with asthma. Table 1 shows their general character-
istics at baseline (at asthma diagnosis) and the descriptive
statistics for mortality. There were 5179 patients (2.78%)who died during the study period (major causes of
death = lung cancer: 10.5%, senility: 6.1%, COPD: 4.5%,
myocardial infarction: 4.4%, and stomach cancer: 3.7%
among total deaths). The average follow-up period was
62.17 months. Patient with sleep disorders more fre-
quently appeared in the died criteria than the survived
criteria. Those who were medical aid beneficiaries also
had a higher risk, as did patients with longer illness du-
rations, severe disabilities, more comorbidities, and higher
pharmaceutical expenditures. With regard to regional vari-
ables, patients in non-metropolitan regions had higher
mortality.
Figure 1 shows Kaplan-Meier survival curves and
log-rank test results of the study population. The aver-
age period from first diagnosis to death was shorter in
patients with sleep disorders (mean: 103.85 months,
standard error [SE]: 0.56) than in those without sleep
disorders (mean: 116.05, SE: 0.04; p < 0.0001).
Table 2 shows the results of the survival analysis using
a Cox proportional hazard model with time-dependent
covariates to investigate the relationship between sleep
disorders and mortality in patients with asthma. Those
with sleep disorders had a greater risk of mortality (with
sleep disorder, hazard ratio [HR]: 1.451, 95% confidence
interval [CI]: 1.253–1.681; reference: without sleep dis-
order). Males and older patients were at greater risk, as
were asthma patients with lower incomes and those who
received medical aid (medical aid, HR: 1.546, 95% CI:
1.317–1.814; NHI self-employed insurance, HR: 1.126,
95% CI: 1.061–1.195; reference: NHI employee insurance).
For regional variables, patients in metropolitan regions
were at lower risk, and higher financial independence
of the local government was inversely associated with
mortality risk.
We performed interaction tests to further examine
potential effect modification of the associations between
sleep disorders and mortality by age, insurance coverage,
pharmaceutical expenditures, region, number of medical
centers per 1000 residents and the CCI. Except for CCI, the
interaction terms between sleep disorders and the men-
tioned variables were not statistically significant. Neverthe-
less, a trend in the magnitude of the stratified HR was
observed for age and insurance coverage. For age, the
highest HR were observed among younger age groups.
For insurance coverage, higher HR were observed for
NHI self-employed insurance than for NHI employee
insurance. In addition, the association between sleep
disorders and mortality was stronger in non-metropolitan
regions compared with metropolitan areas, and among
individuals with lower number of medical centers per
1000 residents. For CCI, the interaction term between
sleep disorders and CCI was statistically significant.
And, higher HR were observed among higher CCI
group (Table 3).
Table 1 General characteristics of the study population
Variable Total Died Survived P-value
n/Mean %/SD n/Mean %/SD n/Mean %/SD
Sleep disorder
Yes 4,565 2.45 320 6.18 4,245 2.34 <0.0001
No 181,926 97.55 4,859 93.82 177,067 97.66
Sex
Male 83,801 44.94 2,819 54.43 80,982 44.66 <0.0001
Female 102,690 55.06 2,360 45.57 100,330 55.34
Age (years)
≤19 80,859 43.36 62 1.20 80,797 44.56 <0.0001
20–29 13,342 7.15 26 0.50 13,316 7.34
30–39 21,861 11.72 89 1.72 21,772 12.01
40–49 20,849 11.18 213 4.11 20,636 11.38
50–59 18,911 10.14 449 8.67 18,462 10.18
60–69 16,170 8.67 1,047 20.22 15,123 8.34
≥70 14,499 7.77 3,293 63.58 11,206 6.18
Income (percentile)
≤10 (low) 14,779 7.92 816 15.76 13,963 7.70 <0.0001
11–20 10,388 5.57 330 6.37 10,058 5.55
21–30 11,584 6.21 370 7.14 11,214 6.18
31–40 13,884 7.44 405 7.82 13,479 7.43
41–50 16,266 8.72 370 7.14 15,896 8.77
51–60 19,443 10.43 421 8.13 19,022 10.49
61–70 22,858 12.26 440 8.50 22,418 12.36
71–80 26,097 13.99 542 10.47 25,555 14.09
81–90 26,628 14.28 716 13.83 25,912 14.29
≥91 (high) 24,564 13.17 769 14.85 23,795 13.12
Insurance coverage
Medical aid 3,934 2.11 269 5.19 3,665 2.02 <0.0001
NHI, self-employed insured 63,816 34.22 2,044 39.47 61,772 34.07
NHI, employee insured 118,741 63.67 2,866 55.34 115,875 63.91
Year of first diagnosis of asthma
2004 23,728 12.72 1,116 21.55 22,612 12.47 <0.0001
2005 23,724 12.72 920 17.76 22,804 12.58
2006 21,994 11.79 709 13.69 21,285 11.74
2007 19,922 10.68 656 12.67 19,266 10.63
2008 19,109 10.25 597 11.53 18,512 10.21
2009 18,064 9.69 455 8.79 17,609 9.71
2010 16,369 8.78 267 5.16 16,102 8.88
2011 16,521 8.86 268 5.17 16,253 8.96
2012 14,947 8.01 149 2.88 14,798 8.16
2013 12,113 6.50 42 0.81 12,071 6.66
Disability
None 179,110 96.04 4,304 83.10 174,806 96.41 <0.0001
Mild 5,874 3.15 581 11.22 5,293 2.92
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Table 1 General characteristics of the study population (Continued)
Severe 1,507 0.81 294 5.68 1,213 0.67
Charlson comorbidity index
≤1 126,882 68.04 328 6.33 126,554 69.80 <0.0001
2 24,752 13.27 405 7.82 24,347 13.43
3 16,685 8.95 890 17.18 15,795 8.71
≥4 18,172 9.74 3,556 68.66 14,616 8.06
Average pharmaceutical expenditures for asthma
in each year (KRW)
24,773.30 ±63,689.71 51,765.29 ±111,475.00 24,002.30 ±61,611.30 <0.0001
Region
Metropolitan 83,723 44.89 2,001 38.64 81,722 45.07 <0.0001
Other 102,768 55.11 3,178 61.36 99,590 54.93
Number of medical centers per 1000 residents 9.17 ±4.39 9.89 ±5.11 9.15 ±4.37 <0.0001
Population size 420,845.64 ±259,860.18 351,277.38 ±259,532.33 422,832.79 ±259,596.53 <0.0001
Proportion of seniors (%) 12.09 ±4.94 14.16 ±6.42 12.03 ±4.87 <0.0001
Financial independence rate of local government (%) 59.06 ±21.79 53.6 ±22.60 59.22 ±21.74 <0.0001
Average follow-up (months) 62.17 ±34.26 38.43 ±28.57 62.85 ±34.17 <0.0001
SD standard deviation; NHI National Health Insurance; KRW Korean Won
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In the past several decades, South Korea has experienced
rapid social and economic growth. The health status of
South Koreans has also improved, and their lifespan has
increased accordingly. Although burdens of illness due
to acute diseases have decreased, chronic conditionsFig. 1 Kaplan-Meier survival curves and log-rank test results comparing sur
without a sleep disorder (solid line)now present new challenges [20]. Many researchers and
healthcare professionals have made efforts to control
such health problems including cancer, cardiovascular
diseases, and cerebrovascular diseases, although certain
issues remain. Specifically, relatively mild chronic dis-
eases are not well managed, including asthma. In thisvival rates between patients with asthma, with (+++, dotted line) or
Table 2 Cox proportional hazard model for association between sleep disorders and mortality
HR 95% CI P-value
Lower Upper
Sleep disorder
Yes 1.451 1.253 1.681 <0.0001
No 1.000 - - -
Sex
Male 2.002 1.893 2.117 <0.0001
Female 1.000 - - -
Age (years)
≤19 1.000 - - -
20–29 2.865 1.809 4.540 <0.0001
30–39 5.823 4.192 8.088 <0.0001
40–49 14.144 10.603 18.866 <0.0001
50–59 24.786 17.431 35.243 <0.0001
60–69 57.397 39.115 84.224 <0.0001
≥70 207.336 138.828 309.651 <0.0001
Income (percentile)
≤10 (low) 1.375 1.228 1.540 <0.0001
11–20 1.390 1.219 1.585 <0.0001
21–30 1.439 1.267 1.634 <0.0001
31–40 1.476 1.306 1.668 <0.0001
41–50 1.289 1.136 1.461 <0.0001
51–60 1.337 1.185 1.507 <0.0001
61–70 1.240 1.101 1.396 0.0004
71–80 1.227 1.098 1.371 0.0003
81–90 1.102 0.994 1.221 0.0651
≥91 (high) 1.000 - - -
Insurance coverage
Medical aid 1.546 1.317 1.814 <0.0001
NHI, self-employed insured 1.126 1.061 1.195 <0.0001
NHI, employee insured 1.000 - - -
Year of asthma diagnosis
2004 1.000 - - -
2005 0.884 0.808 0.967 0.0069
2006 0.765 0.694 0.844 <0.0001
2007 0.859 0.776 0.951 0.0035
2008 0.770 0.692 0.858 <0.0001
2009 0.784 0.697 0.882 <0.0001
2010 0.637 0.552 0.734 <0.0001
2011 0.603 0.518 0.702 <0.0001
2012 0.603 0.501 0.727 <0.0001
2013 0.671 0.487 0.925 0.0148
Disability
None 1.000 - - -
Mild 1.214 1.113 1.326 <0.0001
Han et al. BMC Pulmonary Medicine  (2016) 16:154 Page 6 of 10
Table 2 Cox proportional hazard model for association between sleep disorders and mortality (Continued)
Severe 2.909 2.580 3.280 <0.0001
Charlson comorbidity index
≤1 1.000 - - -
2 1.437 1.122 1.840 0.0041
3 1.568 1.169 2.105 0.0027
≥4 2.019 1.467 2.779 <0.0001
Average annual pharmaceutical expenditures for asthma (per 10,000 KRW increase) 1.003 1.000 1.005 0.018
Region
Metropolitan 0.965 0.897 1.039 0.3419
Other 1.000 - - -
Number of medical centers per 1000 residents (per 5 increase) 1.016 0.987 1.047 0.2789
Population size (per 100,000 increase in population) 0.977 0.962 0.992 0.0029
Proportion of seniors (per 10% increase) 0.940 0.883 1.000 0.0502
Financial independence rate of local government (per 10% increase) 0.978 0.961 0.996 0.0166
CI confidence interval; HR hazard ratio; NHI National Health Insurance; KRW Korean Won
Table 3 Subgroup analysis using Cox proportional hazard model by age, insurance coverage, average pharmaceutical expenditures,
region, and number of medical centers
HR 95% CI P-value
Lower Upper
Age (years)
≤29 7.351 1.735 31.139 0.0068
30–59 1.415 0.865 2.313 0.1665
≥60 1.301 1.097 1.543 0.0025
Insurance coverage
Medical aid 0.690 0.316 1.508 0.3518
NHI, self-employed insured 1.647 1.305 2.078 <0.0001
NHI, employee insured 1.327 1.083 1.626 0.0063
Average annual pharmaceutical expenditures for asthma
Below median 1.447 1.116 1.876 0.0052
Above median 1.466 1.229 1.751 <0.0001
Region
Metropolitan 1.370 1.087 1.727 0.0078
Other 1.508 1.248 1.825 <0.0001
Number of medical centers per 1000 residents
Below median 1.609 1.302 1.988 <0.0001
Above median 1.323 1.079 1.622 0.0071
Charlson comorbidity index
≤2 1.359 1.148 1.610 0.0004
≥3 1.553 1.020 2.364 0.0401
CI confidence interval; HR hazard ratio; NHI National Health Insurance. The results of the subgroup analysis to investigate differences in the association between
sleep disorders and mortality according to age, insurance coverage, average annual pharmaceutical expenditures for asthma, region, number of medical centers,
and Charlson comorbidity index. The P-value in type 3 tests for models with interactions between sleep disorders and subgroup variables were as follows: model
with interaction between age and sleep disorders, P-value in type 3 test = 0.2249; model with interaction between insurance coverage and sleep disorders, P-value
in type 3 test = 0.1742; model with interaction between average annual pharmaceutical expenditures for asthma and sleep disorders, P-value in type 3 test =
0.4199; model with interaction between region and sleep disorders, P-value in type 3 test = 0.3216; model with interaction between number of medical centers
and sleep disorders, P-value in type 3 test = 0.6448; model with interaction between Charlson comorbidity index and sleep disorders, P-value in type
3 test = 0.0427
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[11]. According to health professionals, the difficulties of
asthma management in South Korea are related to short-
comings in primary care, and they have suggested that
continuity of care for asthma patients through primary
care could improve health outcomes in this population.
However, innovative changes in South Korean primary
care are difficult to implement [21]. We focused on the
relationship between sleep disorders and mortality in
asthma patients to determine if addressing this issue
could help this patient population.
Our findings suggest that the presence of sleep disorders
in patients previously diagnosed with asthma is associated
with an increased mortality risk. Previous studies have re-
ported that sleep disorders affect overall quality of life and
can deteriorate patients physically and psychologically
[22–25]. Given the worsening status of asthma manage-
ment and increasing numbers of patients diagnosed with
sleep disorders, we specifically focused on the relationship
between sleep disorders and mortality in patients with
asthma. In South Korea, patients have been able to receive
healthcare with 20%–30% copayment since the introduc-
tion of NHI in 1989 [26]. However, patients who visit med-
ical institutions due to sleep disorders only receive health
insurance coverage for sleep apnea based on the criterion
of the respiratory distress index. This suggests that certain
patients may not have received appropriate treatment.
Therefore, it may be appropriate to revise the insurance
coverage criteria to reduce avoidable death in patients with
asthma. Additionally, improving the accessibility of health-
care by reducing copayments via insurance policy changes
may prevent the worsening status of asthma patients with
sleep disorders, even if there is no direct impact on
mortality. Furthermore, we expect that such an impact
may be helpful in patients with asthma as well as in pa-
tients with other chronic diseases, from a health policy
perspective.
Subgroup analyses revealed several interesting results.
The increased mortality in patients with asthma and sleep
disorders was greater for younger patients, those with NHI
self-employed insurance, those in non-metropolitan areas,
and those in regions with low healthcare accessibility. First,
younger patients had more negative outcomes, which had
been previously reported [27]. This suggests that careful
management for younger asthma patients could prevent
their condition from worsening. Second, patients with
sleep disorders who had NHI self-employed insurance had
a higher mortality rate. This indicates that the evaluation
criteria for beneficiaries of health insurance could benefit
from revision. In South Korea, the government medical aid
program is for patients with an income below the
government-defined poverty level. However, the evalu-
ation for patients who receive NHI self-employed insur-
ance could have overestimated their socioeconomiclevel compared to those with NHI employee insurance
due to evaluation methods. It is therefore possible that
they could have more limited access to healthcare and
might not receive appropriate treatment. Based on these
results, health policymakers must reconsider the evaluation
methods for health insurance beneficiaries [28]. Also,
differences in regional characteristics could affect patient
outcomes. This is another issue that could be addressed
with government interventions. Finally, the significant
interaction between sleep disorders and the CCI was
observed in this study. As already mentioned, CCI was
usually used to consider comorbidities that could affect
health outcomes of patients. Thus, the presence of
interaction means that the occurrence of sleep disorder
in asthma patient with more comorbidities could affect
to more worsening their status, and could not well
manage their condition than patient with less comor-
bidities [29]. Therefore, healthcare professionals were
needed to carefully provide care for patient considering
their comorbidity condition.
Our study had several strengths compared to previous
publications. First, we used national sampling cohort
data to assess the relationship between sleep disorders
and mortality risk in patients with asthma. Such data are
particularly helpful for establishing evidence-based
policies to effectively manage asthma patients. Next,
to the best of our knowledge, this study is the first
study to investigate the impact of sleep disorders on
the mortality risk of asthma patients in South Korea.
Other previous reports described the negative effects
of sleep disorders and relationships between sleep disorders
and health outcomes. However, few studies have regarded
the relationship between sleep disorders and mortality in
patients with asthma in South Korea. Thus, our findings
could provide useful evidence for the development of
policies or programs to better manage patients with
asthma and sleep disorders. Finally, we made a concerted
effort to reduce the limitations of secondary data by
adjusting covariates for patients’ clinical and regional
characteristics. We included the year of asthma diagnosis,
disability, Charlson comorbidity index score, and average
annual pharmaceutical expenditures due to asthma to re-
flect disease severity and included regional characteristics
to consider differences in medical accessibility by area.
Our study also had several limitations. Although several
factors that affect mortality were included in this study,
more detailed information such as socioeconomic factors
was not available [30]. Given that the average period from
the first diagnosis for asthma to death was about 9 years,
there were several potential confounders related to
managing asthma, such as detailed severity indicators
and smoking status, which could have influenced the
health outcomes of patients with asthma. Unfortunately,
we could not assess such confounders in this study due to
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data that were collected to provide payment for both
patients and providers based on medical utilization. Second,
we did not have detailed information regarding patient in-
come level, as the data were collected based on NHI criteria
for the overall economic status of a population; detailed in-
come described in monetary units was not included. Third,
in investigating the association between the occurrences of
sleep disorders and morality as an outcome variable, we
only focused on patients with asthma rather than the
general population. Therefore, there were several concerns
regarding the external validity of the whole population in
this study. Finally, the occurrences of sleep disorders may
have decreased as the status of patients with asthma wors-
ened; thus, they may not have been a direct risk factor for
death. However, we only used all-cause mortality as an out-
come variable in this study rather than measuring symptom
indicators such as pulmonary function test results. There-
fore, we were unable to consider the other changes by oc-
currences of sleep disorders among patients with asthma in
this study, and this may have caused over- or underestima-
tion of the impact of sleep disorders. In addition, although
the data included detailed causes of death, the sample size
was too small to analyze the covariates used in this study
(e.g., respiratory-specific mortality: 0.34%).
Despite these limitations, our findings suggest that sleep
disorders in patients previously diagnosed with asthma are
negatively associated with their health status, and in
particular, mortality. Although further studies using
more detailed data will be needed, these results under-
score the need for health policymakers and healthcare
professionals to identify effective ways to reduce the
prevalence of sleep disorders in South Korea.Conclusion
Sleep disorders in asthma patients are associated with
higher mortality. Considering the worsening status of
asthma management and the rapid growth of sleep
disorders in South Korea, health policymakers should
consider developing effective interventions based on
our findings.
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